Safety
What to do about a GLP-1 adverse reaction
For a GLP-1 adverse reaction, the response depends on severity: supportive care for mild GI symptoms, prompt clinical contact for severe or persistent
For a GLP-1 adverse reaction, the response depends on severity: supportive care for mild GI symptoms, prompt clinical contact for severe or persistent abdominal pain, dehydration, or allergic signs, and emergency care for breathing difficulty or swelling. Do not change your dose on your own; report serious events to your prescriber.
What you need to know
Mild reactions — nausea, mild diarrhea — are common and usually managed with supportive measures and time. The judgment call is recognizing when a symptom crosses from 'expected side effect' to 'get this checked,' which is where the red-flag list matters.
Severe or persistent abdominal pain (possible pancreatitis or gallbladder disease), signs of dehydration from persistent vomiting (kidney-injury risk), and allergic-type symptoms all warrant prompt contact rather than waiting. Breathing difficulty or facial/throat swelling is an emergency.
For compounded products, an unexpected reaction is also a prompt to re-verify the pharmacy and ingredient — an atypical reaction can reflect a product problem, not just the drug. You can also report serious adverse events to the FDA's MedWatch program.
| Symptom | Category | Action |
|---|---|---|
| Mild nausea/diarrhea | Common | Supportive care; monitor |
| Severe/persistent abdominal pain | Serious | Prompt clinical contact (pancreatitis/gallbladder) |
| Persistent vomiting, dehydration | Serious | Contact clinician; rehydrate |
| Swelling, trouble breathing | Emergency | Seek emergency care now |
| Neck lump, hoarseness | Report | Given thyroid warning, tell a clinician |
- Match the symptom to its severity category
- Use supportive care only for mild symptoms
- Contact a clinician for serious symptoms; emergency care for breathing/swelling
- Don't change your dose yourself
- Re-verify the pharmacy/ingredient for compounded products
What the evidence shows
- This guidance reflects FDA compounding information, USP standards, and state board of pharmacy resources.
- Verification steps here are public and checkable.
What the evidence does not show
- That following these steps makes a compounded product FDA-approved — it does not.
- That this page replaces personalized medical or pharmacist advice.
Frequently asked questions
What should I do about GLP-1 nausea?
Supportive care and hydration for mild cases; don't self-adjust dose.
When is a GLP-1 reaction an emergency?
Trouble breathing or facial/throat swelling — seek emergency care immediately.
Related: pharmacy verification hub · safety hub · cost calculator. Compounded medications are not FDA approved.
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.